GERON CORP
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
DE
Business Address
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA, 94404
Mailing Address
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA, 94404
Phone
6504737700
Fiscal Year End
1231
EIN
752287752
Financial Overview
FY2025
-$83.50M
Net Income
$593.78M
Total Assets
$-0.13
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 4 Insider stock transaction report | March 26, 2026 | View on SEC |
| 3 Initial insider ownership report | March 26, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 8-K Current report of material events | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | March 26, 2026 | View on SEC |
| 3 Initial insider ownership report | March 26, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 3, 2026 | View on SEC |
| 10-K Annual financial report | March 2, 2026 | View on SEC |
| 8-K Current report of material events | February 25, 2026 | View on SEC |
Annual Reports
10-K
March 2, 2026
- Submitted New Drug Application (NDA) to the FDA for imetelstat in lower-risk MDS based on positive Phase 3 IMerge clinical trial data.
- Ramped up commercialization efforts, building sales and marketing teams for a potential mid-2024 launch of imetelstat.
Material Events
8-K
Layoffs
December 16, 2025
High Impact
- Geron Corp received FDA approval for Rytelo (imetelstat) in June 2024, marking a major milestone for its flagship product.
- In December 2025, Geron announced a strategic restructuring plan, including a workforce reduction.
Insider Trading
SELL
1 insiders
1 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.